Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation
about
Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation
description
clinical trial
@en
ensayo clínico
@es
klinisch onderzoek
@nl
name
Alendronate in an Weekly Effer ...... wing Denosumab Discontinuation
@en
type
label
Alendronate in an Weekly Effer ...... wing Denosumab Discontinuation
@en
prefLabel
Alendronate in an Weekly Effer ...... wing Denosumab Discontinuation
@en
P4844
P1050
P1476
Alendronate in an Weekly Effer ...... ter Denosumab - The BAD Study)
@en
P17
P1813
BAD
@en
P3098
NCT04338529
P580
2020-04-01T00:00:00Z
P582
2021-10-01T00:00:00Z